Bacteria and their viral enemies, called phages, are in a constant struggle, evolving against each other. A recent study on the International Space Station (ISS) explored how this battle unfolds in microgravity. It offers fascinating insights that could eventually lead to better treatments for antibiotic-resistant bacteria on Earth.
The research, published in PLOS Biology, focused on E. coli infected by T7 phages. While identical cultures were grown on Earth, another set thrived in space. This setup allowed scientists to observe how microgravity changed infection dynamics.
In space, phages managed to infect and kill bacteria, but it took longer compared to their Earth counterparts. An earlier study suggested that slower fluid mixing in microgravity might cause this delay. “This new study confirms our expectations,” said Srivatsan Raman, the lead author and associate professor at the University of Wisconsin-Madison.
On Earth, gravity causes constant movement in fluids, helping bacteria and phages collide more frequently. In microgravity, things merely float. This meant phages had to adapt, becoming more efficient at attaching themselves to passing bacteria.
Experts believe that understanding this unique evolution could lead to better phage therapies. These emerging treatments use phages to target bacteria or boost the effectiveness of traditional antibiotics.
Nicol Caplin, a former astrobiologist at the European Space Agency, said, “If we understand how phages adapt genetically in microgravity, we can apply that knowledge to tackle resistant bacteria on Earth.” This understanding could play a crucial role in the ongoing fight against antibiotic resistance.
The study also showcased that the phages and bacteria on the ISS developed unique genetic mutations not seen in their Earth-bound counterparts. The space phages gained specific adaptations that enhanced their ability to infect, while E. coli evolved defenses to survive — tweaking their receptors to evade attacks.
Using a method known as deep mutational scanning, researchers examined these changes in phages. When the modified phages returned to Earth and were tested, they showed increased effectiveness against E. coli strains that usually resist T7 phages. “It was surprising that the changes from space would make them effective against Earth pathogens,” Raman said.
Charlie Mo, an assistant professor in Bacteriology at the University of Wisconsin-Madison, pointed out the practical implications of these findings. “Space can help enhance phage therapies,” he noted, although he acknowledged the costs involved in sending experiments into space or replicating microgravity on Earth.
This research not only aims to improve health on Earth but could also foster effective therapies for astronauts on long missions, like those to the moon or Mars. With health risks heightened in space, optimizing treatments is vital.
As our understanding of bacteria and phages grows, so does our ability to combat infections. This study is a step forward, showing that even in the vastness of space, we can find solutions that benefit life on Earth.
